ResMed Inc.

NYSE: RMD · Real-Time Price · USD
284.96
0.24 (0.08%)
At close: Aug 15, 2025, 9:58 AM

ResMed Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
1.21B 238.36M 227.89M 273.71M 295.28M
Short-Term Investments
n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
438.96M 284M 262.45M 171.75M 160.92M
Receivables
939.49M 837.27M 704.91M 575.95M 614.29M
Inventory
927.71M 822.25M 998.01M 743.91M 457.03M
Other Current Assets
428.95M 180.01M 179.93M 131.26M n/a
Total Current Assets
3.51B 2.36B 2.37B 1.93B 1.57B
Property-Plant & Equipment
718.29M 699.15M 665.81M 630.5M 592.07M
Goodwill & Intangibles
3.51B 3.33B 3.32B 2.28B 2.32B
Total Long-Term Assets
4.67B 4.51B 4.38B 3.16B 3.15B
Total Assets
8.17B 6.87B 6.75B 5.1B 4.73B
Account Payables
278.16M 237.73M 150.76M 159.25M 138.01M
Deferred Revenue
166.03M 152.55M 138.07M 108.67M 109.61M
Short-Term Debt
40.41M 9.9M 9.9M 9.92M 12M
Other Current Liabilities
n/a 4.65M 9.56M 1.95M n/a
Total Current Liabilities
1.05B 910.65M 758.53M 689.3M 911.77M
Long-Term Debt
658.39M 697.31M 1.43B 765.33M 643.35M
Other Long-Term Liabilities
111.01M 42.26M 105.35M 54.86M 69.73M
Total Long-Term Liabilities
1.16B 1.1B 1.86B 1.05B 930.68M
Total Liabilities
2.21B 2.01B 2.62B 1.74B 1.84B
Total Debt
882.32M 873.93M 1.58B 917.55M 793.72M
Common Stock
761K 588K 588K 586K 583K
Retained Earnings
6.08B 4.99B 4.25B 3.61B 3.08B
Comprehensive Income
-74.7M -251.53M -272.53M -312.75M -193.49M
Shareholders Equity
5.97B 4.86B 4.13B 3.36B 2.89B
Total Investments
n/a n/a n/a n/a n/a